Quality Improvement Program: Chest Pain Outpatient Testing

Slides:



Advertisements
Similar presentations
Patient Oriented Therapy Non STE ACS
Advertisements

Listening to the Data: Why There’s Room for Improvement in MI Care Heartscape® Consultants Meeting Charles V. Pollack, Jr, MA, MD, FACEP, FAAEM, FAHA Chairman,
Rate of Obstructive Coronary Disease in Elective Diagnostic Cath Manesh R. Patel, MD Assistant Professor of Medicine Director Cath Lab Research – Duke.
Comparison of the New Mayo Clinic Risk Scores and Clinical SYNTAX Score in Predicting Adverse Cardiovascular Outcomes following Percutaneous Coronary Intervention.
The Chest Pain Choice Decision Aid: a Randomized Trial ISDM Conference Maastricht, June 2011.
Andrew W. Asimos, MD, FACEP Transient Ischemic Attack Patient Update: The Optimal Management of Emergency Department Patients With Suspected Cerebral Ischemia.
An Emergency Department Diagnostic Protocol For Patients With Transient Ischemic Attack: A Randomized Controlled Trial Michael A. Ross MD Scott Compton.
Development of Clinical Pathways to Streamline Care for Patients Presenting with Suspected Cardiac Chest Pain Background The National Heart Foundation.
Syncope & serial troponins don’t mix Cost Containment Project June 2015 Alex Raufi PGY2.
Spring 2015 ETM 568 Callier, Demers, Drabek, & Hutchison Carter, E. J., Pouch, S. M., & Larson, E. L. (2014). The relationship between emergency department.
The Heart of the Matter A Journey through the system of care.
Amr Hassan Mostafa, MD, FSCAI A. Professor of Cardiology Cairo University Cairo, Egypt Egypt Combat MI, March 24-25, Cairo Sheraton.
CRUSADE: A National Quality Improvement Initiative CRUSADE: A National Quality Improvement Initiative Can Rapid Risk Stratification of Unstable Angina.
Reduction Of Hospital Readmissions Hany Salama, MD Diplomat ABIM IM Hospice and Palliative Care Sleep Medicine.
Sex-Specific Chest Pain Characteristics in AMI Jay Mansfield, Pgy-3 July 22, 2014 LSU Journal Club Gimenez, M, et. Al. Jama Int Med. 2014;174(2):
ACS Clinical Pathway. Who? Pts with Acute Ischemic Heart Disease now described as having ACS.
Prasugrel vs. Clopidogrel for Acute Coronary Syndromes Patients Managed without Revascularization — the TRILOGY ACS trial On behalf of the TRILOGY ACS.
Observation Status Medicare Rules
Will This Admission Help? Leonard Hock, D.O., CMD Covenant Hospice.
6/04 CRUSADE: A National Quality Improvement Initiative C an R apid Risk Stratification of U nstable Angina Patients S uppress AD verse Outcomes with E.
9/8/2008Neumar - Emergency Care Research1 Emergency Care Research Solutions for the U.S. Heath Care System Robert W. Neumar MD, PhD Chair, Research Committee.
Acute Coronary Syndrome David Aymond, MD. ACS Definition: Myocardial ischemia typically due to atherosclerotic plaque rupture  Coronary thrombosis ACS.
Acute Coronary Syndromes Risk-Stratification Pathophysiology Diagnosis Initial Therapy Risk-Stratification Risk-Stratification Invasive vs Conservative.
Chest Pain Advanced Diagnostic Protocol “ADP”. What is it?  The ADP is simply a pathway that can be used to help standardize the care of patients with.
Annual Patient Admissions for Acute Coronary Syndromes 1.4 MM Non-ST elevation ACS 0.6 MM ST-elevation MI ~ 2.0 MM patients admitted to CCU or telemetry.
NSTEMI Pathway Education for Nurses. Objectives Demonstrate an understanding of the NSTEMI clinical pathway. Understand the importance of early and consistent.
Involving Patients with Low Risk Chest Pain in Discharge Decisions: A Multicenter Trial Erik P. Hess MD MSc.
Emergency Department Admission Refusals Requiring Readmission at an Academic Medical Center David R. Kumar MD, Adam E. Nevel MD/MBA, John P. Riordan MD.
FOURIER Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk
Prehospital NSTEMI Patient Assessment and Treatment
Evaluation of CT Coronary Angiography (CTCA) and Cardiac Magnetic Resonance (CMR) in patients presenting with Acute Chest Pain (ACP) at A&E Background.
Risk Stratification of Chest Pain: Best Practices
Prospective evaluation of the use of the thrombolysis in myocardial infarction score as a risk stratification tool for chest pain patients admitted to.
. Troponin limit of detection plus cardiac risk stratification scores for the exclusion of myocardial infarction and 30-day adverse cardiac events in ED.
Floriane Zeyons, MD University Hospital of Strasbourg, France
HEART PATHWAY Brian O’Neal, MD
Journal of Nuclear Cardiology | Official Journal of the American Society of Nuclear Cardiology Comparative Efficiency of Exercise Stress Testing With.
Evaluation of Patients with chest pain Admitted under General Medicine; Has clinical judgment being taken over by serial troponins? Dr. Samantha Herath.
Cocaine-Related Chest Pain: The Year After
Use of ECGs in Assessment of Acute Posterior & Inferior MI’s
Tobias Reichlin, M. D. , Willibald Hochholzer, M. D
Clinical need for determination of vulnerable plaques
Cost Effective Use of Troponin to Rule Out Acute Coronary Syndrome
Eva Kline-Rogers RN, NP, AACC University of Michigan
Evaluating Sepsis Guidelines and Patient Outcomes
Rural Chest Pain Quality Improvement
More Than Survival: Futility
Nicholas D Hartman, M. D. , M. P. H. 1, Kim L. Askew, M. D. 1, David E
European Heart Association Journal 2007 April
Clinical Event Classification: Strategies and Practices
Antiplatelet Therapy Use after Discharge among Acute Myocardial Infarction Patients with In-hospital Bleeding Tracy Y. Wang, MD, MHS, Lan Xiao, PhD, Karen.
Safety of Assessment of Patients With Potential Ischemic Chest Pain in an Emergency Department Waiting Room: A Prospective Comparative Cohort Study  Frank.
TIMI IIIA Protocol Design 391 Patients with Unstable Angina / NQWMI
The European Society of Cardiology Presented by RJ De Winter
Interhospital Transfers to MUSC
Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents: 70 restenotic cases from a cohort of.
Emerging Data Regarding the Potential Benefits of Early Initiation of Clopidogrel Among ACS Patients C. Michael Gibson, M.S., M.D.
Undetectable High Sensitivity Cardiac Troponin T Level in the Emergency Department and Risk of Myocardial Infarction Nadia Bandstein, MD; Rickard Ljung,
Global Registry of Acute Coronary Events: GRACE
Undetectable High Sensitivity Cardiac Troponin T Level in the Emergency Department and Risk of Myocardial Infarction Nadia Bandstein, MD; Rickard Ljung,
Implications of Preoperative Thienopyridine Use
Elevated Admission Plasma Glucose Following ACS
CT coronary angiography and coronary calcium scoring
ARISE Trial Aggressive Reduction of Inflammation Stops Events
Welcome Ask The Experts March 24-27, 2007 New Orleans, LA.
OASIS-5: Study Design Randomize N=20,078 Enoxaparin (N=10,021)
Lecture 4 Study design and bias in screening and diagnostic tests
Chest Pain Choice Trial design: Patients presenting to the ED with low risk chest pain were randomized to either use of a tailored decision aid or routine.
Principal recommendations
Performance of the Manchester Acute Coronary Syndromes decision rule in the derivation study. Performance of the Manchester Acute Coronary Syndromes decision.
Presentation transcript:

Quality Improvement Program: Chest Pain Outpatient Testing Initial Concept and Strong Support from Daniel Himelic, MD Facility Medical Director St. Elizabeth’s Hospital

Chest Pain Workup Background Outpatient Chest Pain Program Documentation Patient Education

Chest Pain Historical Data Most chest pain is not cardiac in nature ( 75-85%) No good screening rule (e.g. PERC) for non-testing High risk, high litigation cohort

Nidus of Reflexive Admission Pope study in 2002 11,000 ED chest pain pt’s 48h follow up 8% MI and 9% unstable angina overall. 2% of MIs missed which was 0.18% of population Study Problems CKMB, not Troponin Listed as failure to diagnose leading to aggressive admission and observation

FHS Internal Data on CP Avg 168 (5.6pt) admits per day with stress tests Avg LOS 1.78 d Possible 9.97 beds per day in system No current system to coordinate outpatient stress test/follow up July 2014-March 2015

HEART Score Clinically based risk stratification rule Designed for ED patient population unlike TIMI Prospectively validated in multiple studies Recognized by TeamHealth Patient Safety Organization as a useful screening tool

Prospective Validation: Backus (2013) 2440 patients with chest pain Ten EDs in the Netherlands Evaluated for MACE within 6 weeks MACE included AMI, PCI, CABG, death HEART score used as compared to GRACE and TIMI with 6 week follow up

Prospective Validation: Results Low HEART Scores (0-3) 36.4% of patients 1.7% MACE Moderate HEART Scores (4-6) 16.6% MACE High HEART Scores (>7) 50.1% MACE

Prospective Validation: Risk Factors Reviewed Percentage of patients in each element of the HEART Score by whether they had MACE or not Points 1 2 MACE No Yes History 45.5 8.6 31.1 27.0 23.3 64.4 EKG 66.8 36.1 19.2 21.1 14.0 42.8 Age 19.0 3.7 43.5 42.0 37.5 54.3 RF 11.2 4.9 36.8 28.5 52.0 66.6 Troponin 92.1 53.6 4.5 13.5 3.4 32.9

US Retrospective Validation: Mahler 2011 Tertiary Residency Training Program (Wake Forest) CDU Patient population 1070 patients Results Low HEART scores (0-3) had 0.6% MACE High HEART Scres (>3) had 4.2% MACE OR of 7.92 Limitations = Pre-selected population of CDU patients, not all ED

Outpatient Chest Pain Program (One Sample Option)

Risk Stratification Program HEART score to identify low risk <3 gets outpatient evaluation >3 traditional admission or treatment Critical Elements Labs – Drawn in ED prior to discharge Outpatient Stress and Appointment Arranged via SJMC HUC log book

ED Labs Drawn and send DO NOT Hemaglobin A1C LAB102 Direct and LDL Cholesterol LAB90 DO NOT Worry about fasting Wait for results

Select Stress Test Need Stress test and MUST BE WITHIN 72 HOURS Medical Follow up for risk stratification

Documentation

Dot Phrase See attached documents for samples to create your own dot phrases / system algorithms for: Heart Score Inclusion Chest Pain Follow up Documentation Includes the guidelines and shared decision making conversation

Quality Follow Up CQIP will review all admissions and discharges with a diagnosis of chest pain looking at: Heart Score Disposition Results of studies Provide feedback on aggregate data on utilization and results Sentinel events or issues should be sent to Nathan Schlicher at Nathan_Schlicher@teamhealth.com for dissemination to the larger group

Education

Patient Education Sample forms for the following are included Patient Instruction sheet for stress test Patient Instruction sheet on where to go Patient Handout Physician Instructions on arranging program Additional examples can be provided upon request

References 1.Meyer MC, Mooney RP, Sekera AK. A critical pathway for patients with acute chest pain and low risk for short-term adverse cardiac events: role of outpatient stress testing.Ann Emerg Med. 2006;47(5):435.e1-3. 2. Pope JH, Aufderheide TP, Ruthazer R, et al. Missed diagnoses of acute cardiac i schemia in the emergency department. N. Engl. J. Med. 2000;342(16):1163-1170. 3. Scheuermeyer FX, Innes G, Grafstein E, et al. Safety and Efficiency of a Chest Pain Diagnostic Algorithm With Selective Outpatient Stress Testing for Emergency Department Patients With Potential Ischemic Chest Pain. Annals of Emergency Medicine. 2012. Available at: http://www.ncbi.nlm.nih.gov/pubmed/22221842. 4. Tricoci P, Allen JM, Kramer JM, Califf RM, Smith SC. Scientific Evidence Underlying the ACC/AHA Clinical Practice Guidelines. JAMA: The Journal of the American Medical Association. 2009;301(8):831 -841. 5. Hess, et al. The Chest Pain Chose Decision Aid: A Randomized Trial. Circ Cardiovasc Qual Outcomes. 2012:5: 251-259 6. Backus, et. al., A prospective validation of the HEART score for chest pain patients at the emergency department. International Journal of Cardiology 168 (2013) 2153-2158